Aniling
VerifiedAccelerating Epigenomics for Precision Medicine against cancer.
Launch date
Employees
Barcelona Catalonia (HQ & founding location)
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 10 % | - | 10 % | - | 4639 % | 40 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (211 %) | (296 %) | (435 %) | (451 %) | 31 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 435 % | (140 %) | (246 %) | (312 %) | 13 % | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
€10.0k | Grant | ||
| Total Funding | 000k | ||
Related Content
Recent News about Aniling
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.